# Medpace Inc – FDA Inspection, Apr 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/medpace-inc/4de49c82-defe-41d5-b071-c87d004f46e4
Source feed: FDA_Inspections

> FDA inspection 1050553 of Medpace Inc, April 20, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050553
- Company Name: Medpace Inc
- Inspection Date: 2018-04-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1332930 - 2026-07-31
- FDA Inspection 1263213 - 2025-02-13
- [FDA Inspection 1245618 - 2024-07-11](https://www.keypedia.com/records/fda_inspections/medpace-inc/73fc50bb-105c-4d98-afdf-261bcc8d5f20)
- [FDA Inspection 1232744 - 2024-03-06](https://www.keypedia.com/records/fda_inspections/medpace-inc/361b5eb5-bbfa-4117-ae30-7c27ba67b824)
- FDA Inspection 1169068 - 2022-04-26

## Related Officers

- [Company Rep](https://www.keypedia.com/people/victoria-m-daddeo/f1832c5e-d242-4e1a-8c30-4c951c3976ea)

Company: https://www.keypedia.com/companies/medpace-inc/e09bfcb9-1613-4cc0-8434-8913be0f770d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
